Objective: To investigate the differential distribution of CXC(CXCL1/2/10) and other inflammatory inducing factors and the relationship between immune inflammation mediated by CXCL1/2/10 and calcium oxalate stone formation. Methods: Firstly, we searched the GEO database to obtain the mRNA sequencing matrix of hypercalciuria rats to analyze the differential genes; After that, the functional enrichment of GO and KEGG was analyzed; Protein interaction analysis(PPI) was used to screen the key molecules; The rat model of calcium oxalate calculus was established by feeding 1% ethylene glycol and intragastric administration of 1% ammonium chloride, and the model was verified by HE staining; In order to verify the expression level of the key molecules, immunohistochemistry was performed in renal tissue sections of calcium oxalate stone rats. Results: A total of 195 differentially expressed genes were obtained based on GEO data, including 146 up-regulated genes and 49 down regulated genes(P<0.05, log2FC<-1 or log2FC>1); Based on Metascape(http://metascape.org/) website, GO and KEGG analysis results showed that genes were enriched in some terms such as GO:0032496:response to lipopolysaccharide, GO:0010942:response to positive regulation of cell death, GO:0002544:response to chronic inflammatory, GO:0006954:response to inflammatory, GO:0072593:response to metabolic process of reactive oxygen species and other metabolic pathways; PPI protein interaction analysis combined with functional enrichment analysis finally identified five key genes:CXCL1, CXCL2, CXCL10, IL6, IL1B; HE staining results showed that the rat model of calcium oxalate stone was successfully constructed, and the results of immunohistochemistry showed that the five key molecules were increased in the model group, the difference was statistically significant(P<0.05), and the expression of CXCL1/2/10 was significantly increased(P<0.001). Conclusion: Based on bioinformatics analysis and experimental verification, this study has found that CXCL1/2/10 is significantly increased in renal tissue of rats with calcium oxalate calculi, which may be related to immune inflammation, suggesting that CXCL1/2/10 may be a potential molecular target for alleviating renal immune inflammation in patients with calcium oxalate calculi and achieving therapeutic effect. |
[1] KHAN S R,PEARLE M S,ROBERTSON W G,et al.Kidney stones[J].Nat Rev Dis Primers,2016,2:16008-16030.
[2] TAGUCHI K,HAMAMOTO S,OKADA A,et al.Genome-wide gene expression profiling of randall's plaques in calcium oxalate stone formers[J].J Am Soc Nephrol,2017,28(1):333-347.
[3] ZHOU Y,ZHOU B,PACHE L,et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J].Nat Commun,2019,10(1):1523-1530.
[4] 叶涛,叶章群.炎症和氧化应激反应与肾结石形成的研究进展[J].中华泌尿外科杂志,2018,39(9):3-5.
[5] 黎承杨,邓耀良.草酸与草酸钙晶体损伤肾脏的机制研究进展[J].中华实验外科杂志,2007,24(12):1616-1618.
[6] STADTMANN A,ZARBOCK A.CXCR2:from bench to bedside[J].Front Immunol,2012,3:263-276.
[7] OLSON T S,LEY K.Chemokines and chemokine receptors in leukocyte trafficking[J].Am J Physiol Regul Integr Comp Physiol,2002,283(1):R7-28.
[8] 程丽娜,宋蔚,闫春妮.IL-8及CXCR1、CXCR2在白内障晶状体上皮细胞中的表达及其意义[J].现代医学,2019,47(10):1197-1201.
[9] COE F L,WORCESTER E M,EVAN A P.Idiopathic hypercalciuria and formation of calcium renal stones[J].Nat Rev Nephrol,2016,12(9):519-533.
[10] TAGUCHI K,OKADA A,HAMAMOTO S,et al.M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development[J].Sci Rep,2016,6:35167-35180.
[11] SHI Q,ZHAO L,XU C,et al.High molecular weight hyaluronan suppresses macrophage M1 polarization and enhances IL-10 production in PM2.5-induced lung inflammation[J].Molecules,2019,24(9):1766-1780.
[12] SHIN S Y,NAM J S,LIM Y,et al.TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines[J].J Biol Chem, 2010,285(40):30731-30740.
[13] LOETSCHER M,GERBER B,LOETSCHER P,et al.Chemokine receptor specific for IP10 and mig:structure,function,and expression in activated T-lymphocytes[J].J Exp Med,1996,184(3):963-969. |